{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:36:19Z","timestamp":1791293779697,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.annder.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T09:49:11Z","timestamp":1334656151000},"page":"350-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Toxicit\u00e9 cutan\u00e9e li\u00e9e \u00e0 la Percutalgine\u00ae\u00a0: analyse de la base nationale de pharmacovigilance"],"prefix":"10.1016","volume":"139","author":[{"given":"C.","family":"Remy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lebrun-Vignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-N.","family":"Beyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mounier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Marsille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mismetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2012.03.002_bib0005","series-title":"Commission de la transparence","author":"HAS","year":"2011"},{"key":"10.1016\/j.annder.2012.03.002_bib0010","unstructured":"Sean C. Sweetman, ed. (2007). Martindale: The Complete Drug Reference (35th edition ed.). London: Pharmaceutical Press"},{"key":"10.1016\/j.annder.2012.03.002_bib0015","first-page":"55","article-title":"Bilan de l\u2019enqu\u00eate nationale sur les effets secondaires cutan\u00e9s du gel de k\u00e9toprof\u00e8ne enregistr\u00e9s entre septembre 1996\u00a0et ao\u00fbt 2000","volume":"57","author":"Veyrac","year":"2002","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.annder.2012.03.002_bib0020","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.2310\/6620.2010.09090","article-title":"Allergic contact dermatitis from ethylhexyl salicylate and other salicylates","volume":"21","author":"Mortz","year":"2010","journal-title":"Dermatitis"},{"key":"10.1016\/j.annder.2012.03.002_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1034\/j.1600-0536.2002.470210_12.x","article-title":"Contact dermatitis from anti-inflammatory gel containing hydroxyethyl salicylate","volume":"47","author":"Horak","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.annder.2012.03.002_bib0030","first-page":"527","article-title":"Contact dermatitis due to topical drugs","volume":"144","author":"Barbaud","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.03.002_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/187221309787158425","article-title":"Contact allergy to topical corticosteroids: update and review on cross-sensitization","volume":"3","author":"Foti","year":"2009","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1016\/j.annder.2012.03.002_bib0040","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1398-9995.2009.02038.x","article-title":"Allergic hypersensitivity to topical and systemic corticosteroids: a review","volume":"64","author":"Baek","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.annder.2012.03.002_bib0045","unstructured":"Afssaps. Liste des excipients \u00e0 effet notoire. http:\/\/www.afssaps.fr\/var\/afssaps_site\/storage\/original\/application\/29aa941a3e557fb62cbe45ab09dce305.pdf."},{"key":"10.1016\/j.annder.2012.03.002_bib0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2310\/6620.2008.08039","article-title":"Positive patch test reactions to propylene glycol: a retrospective cross-sectional analysis from the North American Contact Dermatitis Group, 1996\u00a0to 2006","volume":"20","author":"Warshaw","year":"2009","journal-title":"Dermatitis"},{"key":"10.1016\/j.annder.2012.03.002_bib0055","first-page":"5","article-title":"Propylene glycol: an often unrecognized cause of allergic contact dermatitis in patients using topical corticosteroids","volume":"16","author":"Al Jasser","year":"2011","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.annder.2012.03.002_bib0060","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1398-9995.2007.01616.x","article-title":"Salicylamide-induced anaphylaxis: increased urinary leukotriene E4\u00a0and prostaglandin D2\u00a0metabolite","volume":"63","author":"Ono","year":"2008","journal-title":"Allergy"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963812001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963812001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:59:08Z","timestamp":1758970748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963812001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0151963812001196"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2012.03.002","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicit\u00e9 cutan\u00e9e li\u00e9e \u00e0 la Percutalgine\u00ae\u00a0: analyse de la base nationale de pharmacovigilance","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2012.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}